文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

初始非可除颤心律心脏骤停患者的靶向温度管理:系统评价与Meta分析

Targeted Temperature Management in Cardiac Arrest Patients With an Initial Non-Shockable Rhythm: A Systematic Review and Meta-Analysis.
PubMed 文献 · Shock · 2020-01-01
一句话结论初始非可除颤心律心脏骤停后,靶向温度管理(目标32°C-34°C)与短期和长期生存率及良好神经功能结局相关,但仅纳入RCT的敏感性分析未达统计学显著,试验序贯分析认为结论不确定。

该系统评价与Meta分析纳入30项研究(25项观察性研究和5项RCT),共10,703例初始非可除颤心律心脏骤停患者,其中4,023例接受靶向温度管理(TTM,目标32°C-34°C)联合标准治疗,6,680例仅接受标准治疗。汇总分析显示,与标准治疗相比,TTM组短期生存率(OR 1.44,95%CI 1.15-1.81;P=0.002)、长期生存率(OR 1.52,95%CI 1.03-2.26;P=0.04)和CPC评分1-2分(OR 1.63,95%CI 1.22-2.17;P=0.0010)均显著更高。但仅纳入RCT的敏感性分析显示短期生存率(OR 1.25,95%CI 0.82-1.89;P=0.30)、长期生存率(OR 1.15,95%CI 0.80-1.66;P=0.46)和神经功能结局(OR 1.51,95%CI 0.81-2.80;P=0.19)均未达统计学显著,试验序贯分析提示结论不确定。

要点

  • 汇总30项研究(10,703例)显示,初始非可除颤心律心脏骤停后接受TTM(目标32°C-34°C)者短期生存率高于标准治疗(OR 1.44,95%CI 1.15-1.81;P=0.002)。
  • 长期生存率(OR 1.52,95%CI 1.03-2.26;P=0.04)和CPC评分1-2分(OR 1.63,95%CI 1.22-2.17;P=0.0010)在TTM组同样更高,但证据来自观察性研究为主的汇总。
  • 仅纳入5项RCT的敏感性分析中,短期生存率(OR 1.25,95%CI 0.82-1.89;P=0.30)、长期生存率(OR 1.15,95%CI 0.80-1.66;P=0.46)和神经功能结局(OR 1.51,95%CI 0.81-2.80;P=0.19)均未达统计学显著。
  • 对RCT进行的试验序贯分析显示结果不确定,RCT分析不支持汇总分析的结论。

适用人群与场景

  • 初始非可除颤心律(NSR)的心脏骤停患者,比较靶向温度管理(TTM)联合标准治疗与单纯标准治疗。

处置流程与药物剂量

  • TTM目标温度为32°C-34°C,与标准治疗进行比较;原文未给出降温启动时机、维持时长、复温速率及具体实施方法。

研究设计与关键结果

  • 研究设计:系统评价与Meta分析,纳入30项研究(25项观察性研究和5项RCT),共10,703例患者,其中TTM组4,023例、单纯标准治疗组6,680例。
  • 主要终点:与标准治疗相比,TTM组短期生存率更高(OR 1.44,95%CI 1.15-1.81;P=0.002)、长期生存率更高(OR 1.52,95%CI 1.03-2.26;P=0.04)、CPC评分1-2分比例更高(OR 1.63,95%CI 1.22-2.17;P=0.0010)。
  • 仅纳入RCT的敏感性分析:短期生存率OR 1.25(95%CI 0.82-1.89;P=0.30)、长期生存率OR 1.15(95%CI 0.80-1.66;P=0.46)、神经功能结局OR 1.51(95%CI 0.81-2.80;P=0.19),均未达统计学显著。
  • 对RCT进行的试验序贯分析显示结果不确定。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,纳入25项观察性研究和5项RCT;原文未报告证据等级或推荐强度。
  • 局限:仅纳入RCT的敏感性分析未达统计学显著;试验序贯分析显示RCT结果不确定;原文结论指出RCT分析不支持汇总分析的结论。

对床旁实践的改变

  • 汇总分析提示初始非可除颤心律心脏骤停后TTM与更高的短期生存率、长期生存率和良好神经功能结局相关,但仅RCT分析未达统计学显著且试验序贯分析结果不确定,作者结论为RCT分析不支持该结论。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Targeted temperature management (TTM) is now recommended for patients presenting with an out-of-hospital cardiac arrest. However, there are limited data that support its use in patients with an initial non-shockable rhythm (NSR).

METHODS: A literature search of PubMed/MEDLINE, Cochrane Library, and Embase was conducted by two independent authors for studies that compared TTM along with standard care versus standard care alone in treating cardiac arrest with initial NSR. Outcomes were short-term and long-term survival, and a Cerebral Performance Category (CPC) score of 1 to 2 at the longest follow-up period. The Mantel-Haenszel random-effects model was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Trial sequential analysis (TSA) was performed on the randomized controlled trials (RCTs).

RESULTS: Thirty studies were included in the final analysis: 25 observational and five RCTs, totalling 10,703 patients, 4,023 of whom received TTM and 6,680 received standard care alone. Compared with standard care, patients who presented with an initial NSR cardiac arrest and received TTM (target of 32°C -34°C) had a significantly higher short-term survival (OR 1.44 95% CI 1.15-1.81; P = 0.002), long-term survival (OR 1.52 95% CI 1.03-2.26; P = 0.04), and CPC score of 1 to 2 (OR 1.63 95% CI 1.22-2.17; P = 0.0010). Sensitivity analyses by including only RCTs showed a trend, although not significant, toward better short-term survival (OR 1.25 95% CI 0.82-1.89; P = 0.30), long-term survival (OR 1.15 95% CI 0.80-1.66; P = 0.46), and neurologic outcomes (OR 1.51 95% CI 0.81-2.80; P = 0.19). However, TSA performed on the RCTs revealed that the results were inconclusive.

CONCLUSION: Among patients who survived cardiac arrest with an initial NSR, TTM is associated with a higher rate of survival and favorable neurological outcomes compared with no TTM. However, analyses from the included RCTs did not support this conclusion.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Barbarawi M, Alabdouh A, Barbarawi O, et al. Targeted Temperature Management in Cardiac Arrest Patients With an Initial Non-Shockable Rhythm: A Systematic Review and Meta-Analysis. Shock. 2020. PMID: 32433212. doi:10.1097/SHK.0000000000001550

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。